Piperidinone carboxamide azaindane CGRP receptor antagonists
US8481556B2 · kind B2 · utility
17Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 10, 2011 |
| Grant date | Jul 9, 2013 |
| Priority date | — |
| Expiry date | Nov 10, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.